CAR T-cells specific for tumor endothelial marker 8 (TEM8), a cell surface protein that functions in endothelial cell migration and invasion, are effective not only against TNBC cells but also against the associated tumor endothelium [198]. This evidence concerns the gene ANTXR1 and neoplasm.